We are the seed accelerator of Charleroi Brussels South Biopark
In a study published in Nature, research team led by Prof. Cédric Blanpain, MD/PhD, WELBIO investigator and Professor at the Université libre de Bruxelles, Belgium, identified for the first time, the different tumor transition states occurring during cancer progression and identified subpopulations of tumor cells responsible for metastasis in skin squamous cell carcinoma, the second most frequent cancer worldwide, and breast cancer, the most frequent cancers in women. Please find the official press release of ULB here.
Spectralys Biotech, an in-creation ULB spin-off offering innovative analytical solutions for biomolecules based on infrared spectroscopy (FTIR), is looking for a Business Developer to promote adoption of its technology in the biopharmaceutical industry. Interested? Please find the job offering and contact details here.Read more